新型多巴胺D4受体、5-羟色胺2a (5-HT2A)受体和α1肾上腺素受体拮抗剂NRA0045的非典型抗精神病药物特征

{"title":"新型多巴胺D4受体、5-羟色胺2a (5-HT2A)受体和α1肾上腺素受体拮抗剂NRA0045的非典型抗精神病药物特征","authors":"S. Chaki, A. Nakazato, S. Okuyama","doi":"10.1111/J.1527-3458.2000.TB00140.X","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10499,"journal":{"name":"CNS drug reviews","volume":"248 1","pages":"95-110"},"PeriodicalIF":0.0000,"publicationDate":"2006-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Atypical Antipsychotic Profile of NRA0045, a Novel Dopamine D4 receptor, 5-Hydroxytryptamine2A (5-HT2A) Receptor and α1 Adrenoceptor Antagonist\",\"authors\":\"S. Chaki, A. Nakazato, S. Okuyama\",\"doi\":\"10.1111/J.1527-3458.2000.TB00140.X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10499,\"journal\":{\"name\":\"CNS drug reviews\",\"volume\":\"248 1\",\"pages\":\"95-110\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-06-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CNS drug reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/J.1527-3458.2000.TB00140.X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS drug reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1527-3458.2000.TB00140.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}